A citation-based method for searching scientific literature

Carolyn Stull, Michael J Lavery, Gil Yosipovitch. Expert Opin Pharmacother 2016
Times Cited: 15







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?
Nicholas K Mollanazar, Peter K Smith, Gil Yosipovitch. Clin Rev Allergy Immunol 2016
175
40

Clinical classification of itch: a position paper of the International Forum for the Study of Itch.
Sonja Ständer, Elke Weisshaar, Thomas Mettang, Jacek C Szepietowski, Earl Carstens, Akihiko Ikoma, Nora V Bergasa, Uwe Gieler, Laurent Misery, Joanna Wallengren,[...]. Acta Derm Venereol 2007
389
40

Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque Psoriasis.
Jeffrey M Sobell, Peter Foley, Darryl Toth, Ulrich Mrowietz, Giampiero Girolomoni, Joana Goncalves, Robert M Day, Rongdean Chen, Gil Yosipovitch. Acta Derm Venereol 2016
40
33

Clinical practice. Chronic pruritus.
Gil Yosipovitch, Jeffrey D Bernhard. N Engl J Med 2013
233
33

The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis.
G Yosipovitch, A Goon, J Wee, Y H Chan, C L Goh. Br J Dermatol 2000
270
26

Current topical and systemic therapies for itch.
Tabi Anika Leslie, Malcolm W Greaves, Gil Yosipovitch. Handb Exp Pharmacol 2015
30
26

The neurobiology of itch.
Akihiko Ikoma, Martin Steinhoff, Sonja Ständer, Gil Yosipovitch, Martin Schmelz. Nat Rev Neurosci 2006
608
26

Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy.
Sonja Ständer, Dorothee Siepmann, Ilka Herrgott, Cord Sunderkötter, Thomas A Luger. PLoS One 2010
191
26

Mirtazapine for pruritus.
Mellar P Davis, Jan L Frandsen, Declan Walsh, Steven Andresen, Sandy Taylor. J Pain Symptom Manage 2003
113
20

Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
Jennifer L Hundley, Gil Yosipovitch. J Am Acad Dermatol 2004
104
20

Psychological Interventions in the Treatment of Chronic Itch.
Christina Schut, Nicholas K Mollanazar, Jörg Kupfer, Uwe Gieler, Gil Yosipovitch. Acta Derm Venereol 2016
51
20

Butorphanol for treatment of intractable pruritus.
Aerlyn G Dawn, Gil Yosipovitch. J Am Acad Dermatol 2006
120
20

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Christopher E M Griffiths, Kristian Reich, Mark Lebwohl, Peter van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, Janelle Erickson, Lu Zhang, Roberta J Secrest,[...]. Lancet 2015
563
20

Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.
David Roblin, Gil Yosipovitch, Brent Boyce, John Robinson, James Sandy, Valentina Mainero, Ro Wickramasinghe, Uma Anand, Praveen Anand. Acta Derm Venereol 2015
72
20

Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Andreas E Kremer, Remco van Dijk, Pamela Leckie, Frank G Schaap, Edith M M Kuiper, Thomas Mettang, Katrin S Reiners, Ulrike Raap, Henk R van Buuren, Karel J van Erpecum,[...]. Hepatology 2012
172
20

Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.
Leigh A Nattkemper, Maria-Estela Martinez-Escala, Ari B Gelman, Elisha M Singer, Alain H Rook, Joan Guitart, Gil Yosipovitch. Acta Derm Venereol 2016
66
20

Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Thomas Ruzicka, Jon M Hanifin, Masutaka Furue, Grazyna Pulka, Izabela Mlynarczyk, Andreas Wollenberg, Ryszard Galus, Takafumi Etoh, Ryosuke Mihara, Hiroki Yoshida,[...]. N Engl J Med 2017
320
20

Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.
Amy S Paller, Wynnis L Tom, Mark G Lebwohl, Robin L Blumenthal, Mark Boguniewicz, Robert S Call, Lawrence F Eichenfield, Douglass W Forsha, William C Rees, Eric L Simpson,[...]. J Am Acad Dermatol 2016
274
20

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
Eric L Simpson, Thomas Bieber, Emma Guttman-Yassky, Lisa A Beck, Andrew Blauvelt, Michael J Cork, Jonathan I Silverberg, Mette Deleuran, Yoko Kataoka, Jean-Philippe Lacour,[...]. N Engl J Med 2016
941
20

Mirtazapine, an antidepressant.
T Puzantian. Am J Health Syst Pharm 1998
44
13

Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.
Martin Steinhoff, John Bienenstock, Martin Schmelz, Marcus Maurer, Ed Wei, Tamás Bíró. J Invest Dermatol 2006
177
13

The neurology of itch.
Amar Dhand, Michael J Aminoff. Brain 2014
77
13

Therapy of pruritus.
Tejesh Patel, Gil Yosipovitch. Expert Opin Pharmacother 2010
80
13

Bed bugs revisited.
Michael Joseph Lavery, Lawrence Charles Parish. Skinmed 2011
3
66

Chronic pruritus in the elderly: pathophysiology, diagnosis and management.
Rodrigo Valdes-Rodriguez, Carolyn Stull, Gil Yosipovitch. Drugs Aging 2015
43
13

Neuropathic and psychogenic itch.
Gil Yosipovitch, Lena S Samuel. Dermatol Ther 2008
106
13

Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Ronald L Pisoni, Björn Wikström, Stacey J Elder, Tadao Akizawa, Yashushi Asano, Marcia L Keen, Rajiv Saran, David C Mendelssohn, Eric W Young, Friedrich K Port. Nephrol Dial Transplant 2006
289
13

Clinical characteristics of pruritus in chronic idiopathic urticaria.
G Yosipovitch, N Ansari, A Goon, Y H Chan, C L Goh. Br J Dermatol 2002
97
13

Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes.
José L Jimenez, Miguel A Iñiguez, M Angeles Muñoz-Fernández, Manuel Fresno. Cell Signal 2004
25
13

Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies.
L T Zane, S Chanda, K Jarnagin, D B Nelson, L Spelman, Lf Stein Gold. Immunotherapy 2016
40
13

A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves.
Hisashi Wakita, Masayoshi Ohkuro, Naoto Ishii, Ieharu Hishinuma, Manabu Shirato. Exp Dermatol 2015
12
16

Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.
J M Hanifin, S C Chan, J B Cheng, S J Tofte, W R Henderson, D S Kirby, E S Weiner. J Invest Dermatol 1996
167
13



Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity.
P H Schafer, A Parton, L Capone, D Cedzik, H Brady, J F Evans, H-W Man, G W Muller, D I Stirling, R Chopra. Cell Signal 2014
185
13

Topical capsaicin. The fire of a 'hot' medicine is reignited.
Alexandru D P Papoiu, Gil Yosipovitch. Expert Opin Pharmacother 2010
53
13


Validation and response to treatment of a pruritus self-assessment tool in patients with moderate to severe psoriasis.
Alice Gottlieb, Jingyuan Feng, David J Harrison, Denise Globe. J Am Acad Dermatol 2010
15
13

Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire.
Jenna L O'Neill, Yiong Huak Chan, Stephen R Rapp, Gil Yosipovitch. Acta Derm Venereol 2011
57
13

Pruritus is an important factor negatively influencing the well-being of psoriatic patients.
Adam Reich, Ewa Hrehorów, Jacek C Szepietowski. Acta Derm Venereol 2010
140
13

Treatment of pruritic diseases with topical calcineurin inhibitors.
Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar. Ther Clin Risk Manag 2006
53
13

Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.
Joaquín Sola-Ortigosa, Manuel Sánchez-Regaña, Pablo Umbert-Millet. J Dermatolog Treat 2012
17
13

Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
A B Kimball, A N Naegeli, E Edson-Heredia, C-Y Lin, C Gaich, E Nikaï, K Wyrwich, G Yosipovitch. Br J Dermatol 2016
58
13

The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers.
Emiko Senba, Kimiaki Katanosaka, Hiroki Yajima, Kazue Mizumura. Neurosci Res 2004
43
13

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.
V J Ludbrook, K J Hicks, K E Hanrott, J S Patel, M H Binks, M R Wyres, J Watson, P Wilson, M Simeoni, L A Schifano,[...]. Br J Dermatol 2016
48
13

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial.
Diamant Thaçi, Andrew Blauvelt, Kristian Reich, Tsen-Fang Tsai, Francisco Vanaclocha, Külli Kingo, Michael Ziv, Andreas Pinter, Sophie Hugot, Ruquan You,[...]. J Am Acad Dermatol 2015
369
13

Pruritus severity in patients with psoriasis is not correlated with psoriasis disease severity.
David Roblin, Ro Wickramasinghe, Gil Yosipovitch. J Am Acad Dermatol 2014
33
13

A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis.
K A Papp, M A Menter, M Raman, D Disch, D E Schlichting, C Gaich, W Macias, X Zhang, J M Janes. Br J Dermatol 2016
146
13

Effect of EMLA pre-treatment on capsaicin-induced burning and hyperalgesia.
G Yosipovitch, H I Maibach, M C Rowbotham. Acta Derm Venereol 1999
41
13

Nocturnal Pruritus: The Battle for a Peaceful Night's Sleep.
Michael Joseph Lavery, Carolyn Stull, Michael Owen Kinney, Gil Yosipovitch. Int J Mol Sci 2016
53
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.